These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 15853623

  • 1. Therapy for neurocysticercosis.
    Takayanagui OM.
    Expert Rev Neurother; 2004 Jan; 4(1):129-39. PubMed ID: 15853623
    [Abstract] [Full Text] [Related]

  • 2. Medical management of neurocysticercosis.
    Takayanagui OM, Odashima NS, Bonato PS, Lima JE, Lanchote VL.
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
    Kaur S, Singhi P, Singhi S, Khandelwal N.
    Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
    [Abstract] [Full Text] [Related]

  • 4. Praziquantel therapy in neurocysticercosis.
    Gogna A.
    J Assoc Physicians India; 1996 Feb; 44(2):149. PubMed ID: 10999076
    [No Abstract] [Full Text] [Related]

  • 5. [Therapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosis].
    Guo DM, Xie SP, Jia JP.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2003 Feb; 21(3):187-8. PubMed ID: 14628357
    [No Abstract] [Full Text] [Related]

  • 6. Drug treatment of neurocysticercosis.
    Garg RK.
    Natl Med J India; 1997 Feb; 10(4):173-7. PubMed ID: 9325640
    [Abstract] [Full Text] [Related]

  • 7. One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial.
    Singhi P, Dayal D, Khandelwal N.
    Pediatr Infect Dis J; 2003 Mar; 22(3):268-72. PubMed ID: 12634590
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J, Jung H.
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [Abstract] [Full Text] [Related]

  • 9. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
    Proaño JV, Madrazo I, Avelar F, López-Félix B, Díaz G, Grijalva I.
    N Engl J Med; 2001 Sep 20; 345(12):879-85. PubMed ID: 11565520
    [Abstract] [Full Text] [Related]

  • 10. Medical management of neurocysticercosis.
    Garg RK.
    Neurol India; 2001 Dec 20; 49(4):329-37. PubMed ID: 11799403
    [Abstract] [Full Text] [Related]

  • 11. Treatment of neurocysticercosis: is it beneficial?
    Garg RK.
    Expert Rev Anti Infect Ther; 2008 Aug 20; 6(4):435-40. PubMed ID: 18662110
    [Abstract] [Full Text] [Related]

  • 12. Neurocysticercosis in a European traveler returning from India primarily suspected as neoplasia.
    Salzer HJ, Hoenigl M, Valentin T, Zollner-Schwetz I, Krause R.
    J Travel Med; 2013 Aug 20; 20(5):333-5. PubMed ID: 23992578
    [Abstract] [Full Text] [Related]

  • 13. [Chemotherapy of cysticercosis. Review about its pharmacokinetics and toxicology].
    Herrera LA, Benítez-Bribiesca L, Sotelo J, Ostrosky-Wegman P.
    Gac Med Mex; 2000 Aug 20; 136(5):477-89. PubMed ID: 11080931
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of medical treatment of neurocysticercosis: a study of 65 cases in Cheju Island, Korea.
    Kim SK, Wang KC, Paek SH, Hong KS, Cho BK.
    Surg Neurol; 1999 Dec 20; 52(6):563-9. PubMed ID: 10660021
    [Abstract] [Full Text] [Related]

  • 15. Current approaches to cysticidal drug therapy for neurocysticercosis.
    Del Brutto OH.
    Expert Rev Anti Infect Ther; 2020 Aug 20; 18(8):789-798. PubMed ID: 32331507
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic approach to neurocysticercosis].
    Canak G, Ilić A.
    Med Pregl; 1998 Aug 20; 51 Suppl 1():57-60. PubMed ID: 9769658
    [Abstract] [Full Text] [Related]

  • 17. Short course of albendazole therapy for neurocysticercosis.
    Alarcón F, Maldonado JC.
    Clin Neurol Neurosurg; 2006 Dec 20; 108(8):810-1. PubMed ID: 16647198
    [No Abstract] [Full Text] [Related]

  • 18. [About an autochtonous case of neurocysticercosis in Mali].
    Maïga Y, Diallo M, Bouteille B, Konate A, Diarra M, Maïga M, Marjolet M.
    Bull Soc Pathol Exot; 2009 Oct 20; 102(4):211-4. PubMed ID: 19950534
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
    Garcia HH, Gonzales I, Lescano AG, Bustos JA, Zimic M, Escalante D, Saavedra H, Gavidia M, Rodriguez L, Najar E, Umeres H, Pretell EJ, Cysticercosis Working Group in Peru.
    Lancet Infect Dis; 2014 Aug 20; 14(8):687-695. PubMed ID: 24999157
    [Abstract] [Full Text] [Related]

  • 20. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.
    Göngora-Rivera F, Soto-Hernández JL, González Esquivel D, Cook HJ, Márquez-Caraveo C, Hernández Dávila R, Santos-Zambrano J.
    Neurology; 2006 Feb 14; 66(3):436-8. PubMed ID: 16382035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.